活体肾脏捐献后的妊娠结局
这项加拿大匹配队列研究纳入1992年7月至2021年8月期间捐献肾脏、年龄18至42岁且其后有≥20周单胎妊娠的女性捐献者385例次妊娠,按1:4匹配非捐献者1540例次妊娠。结果显示主要复合结局(因妊娠期高血压、子痫前期或子痫住院)在捐献者中发生率为11.9%,非捐献者为8.3%,风险比1.51(95% CI 1.10-2.08)。12项次要结局中仅小于胎龄儿风险比95% CI排除1.00:捐献者13.8%,非捐献者7.9%,风险比1.86(95% CI 1.37-2.52)。多数捐献后妊娠无并发症。
要点
- 活体肾捐献后妊娠的主要复合结局(妊娠期高血压、子痫前期或子痫住院)发生率为11.9%,匹配非捐献者为8.3%,风险比1.51(95% CI 1.10-2.08)。
- 小于胎龄儿在捐献者妊娠中发生率为13.8%,非捐献者为7.9%,风险比1.86(95% CI 1.37-2.52),是12项次要结局中唯一95% CI排除1.00者。
- 低出生体重或早产复合结局、主要复合结局各单独组分等其余11项次要结局的95% CI均包含1.00,原文未报告具体效应量数值。
- 多数捐献后妊娠无并发症,该发现支持对可能妊娠的捐献候选者告知此风险,并对妊娠捐献者加强产前监护。
适用人群与场景
- 加拿大安大略省、不列颠哥伦比亚省、阿尔伯塔省1992年7月至2021年8月间捐献肾脏、捐献时年龄18至42岁、其后有≥20周单胎妊娠的女性活体肾捐献者,共385例次妊娠、252名捐献者。
- 匹配非捐献者妊娠:按分娩日期、分娩时年龄、入组至分娩年数、既往妊娠次数和收入以1:4匹配的≥20周单胎妊娠,共1540例次、1535名非捐献者。
- 随访截至2023年3月,结局分析时间为2024年8月至2026年9月。
诊断标准与关键阈值
- 主要结局标准:因妊娠期高血压、子痫前期或子痫诊断住院的复合结局,原始数据来自省级行政健康数据库。
- 次要结局共12项,包括主要结局各单独组分、低出生体重或早产复合结局、小于胎龄儿等母体、胎儿和新生儿不良结局。
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究类型:使用加拿大省级行政健康数据库的匹配队列研究,捐献者妊娠按1:4匹配非捐献者妊娠。
- 主要结局:捐献者妊娠中46例(11.9%)发生妊娠期高血压、子痫前期或子痫复合结局,非捐献者128例(8.3%),风险比1.51(95% CI 1.10-2.08)。
- 次要结局:小于胎龄儿在捐献者妊娠中53例(13.8%),非捐献者121例(7.9%),风险比1.86(95% CI 1.37-2.52),为12项次要结局中唯一95% CI排除1.00者。
- 其余11项次要结局的风险比95% CI均包含1.00,原文未逐个报告效应量数值。
- 捐献者妊娠平均年龄27.8(SD 5.0)岁,非捐献者27.0(SD 4.8)岁。
证据类型、等级与局限
- 证据类型:匹配队列研究。
- 局限:原文未明确讨论局限性;设计上采用行政健康数据库回顾性识别结局,依赖诊断编码。
对床旁实践的改变
- 对急诊或ICU床旁实践的直接改变原文未提及;研究支持对可能妊娠的活体肾捐献候选者告知妊娠期高血压、子痫前期或子痫复合结局风险增高。
- 研究提示对既往活体肾捐献的妊娠者应加强产前监护,原文未给出具体监护方案或急诊处置建议。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: People who become pregnant after living kidney donation may be at increased risk of pregnancy-related adverse outcomes, although the evidence is unclear.
OBJECTIVE: To determine whether pregnancies after living kidney donation are associated with a higher risk of adverse pregnancy outcomes than matched pregnancies among nondonors.
DESIGN, SETTING, AND PARTICIPANTS: This matched cohort study used provincial administrative health care databases from Ontario, British Columbia, and Alberta, Canada, and included living female kidney donors aged 18 to 42 years who donated a kidney between July 1992 and August 2021 and subsequently had singleton pregnancies of at least 20 weeks' gestation. These pregnancies were matched 1:4 with singleton pregnancies of at least 20 weeks' gestation among female nondonors. Pregnancies in donors and nondonors were matched on delivery date, age at delivery, years between cohort entry and delivery, number of prior pregnancies, and income. Final follow-up occurred until March 2023. Outcome analysis occurred from August 2024 to September 2026.
MAIN OUTCOMES AND MEASURES: The primary outcome was a composite of hospitalization with a diagnosis of gestational hypertension, preeclampsia, or eclampsia. Secondary outcomes included 12 maternal, fetal and neonatal adverse outcomes, including the individual components of the primary outcome, the composite of low birth weight or preterm birth, and small for gestational age at birth.
RESULTS: The sample included 385 pregnancies in 252 living kidney donors (mean [SD] age, 27.8 [5.0] years) matched to 1540 pregnancies in 1535 nondonors (mean [SD] age, 27.0 [4.8] years). The primary composite outcome of gestational hypertension, preeclampsia, or eclampsia occurred in 46 donor pregnancies (11.9%) and 128 nondonor pregnancies (8.3%; risk ratio, 1.51; 95% CI, 1.10-2.08). Among the 12 secondary outcomes, the 95% CI for the risk ratio excluded 1.00 for the outcome of small for gestational age, which occurred in 53 donor pregnancies (13.8%) and 121 nondonor pregnancies (7.9%) (risk ratio, 1.86; 95% CI, 1.37-2.52).
CONCLUSIONS AND RELEVANCE: In this study, pregnancy after living kidney donation was associated with a higher risk of the composite outcome of hospitalization with a diagnosis of gestational hypertension, preeclampsia, or eclampsia, when compared with matched pregnancies in nondonors. Most postdonation pregnancies were uncomplicated. These findings support counseling donor candidates who may become pregnant about this risk and informing the prenatal care of donors who become pregnant.
参考来源
- Wang, Naylor, McArthur, et al. Pregnancy Outcomes After Living Kidney Donation. JAMA. 2026. PMID: 42914154. doi:10.1001/jama.2026.21737
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。